Kazia Therapeutics Limited

Kazia Therapeutics Limited could be a weak company given it's low Piotroski F-score. This stock has a reasonable momentum. Tradey thinks it is not wise to invest in Kazia Therapeutics Limited.
Log in to see more information.
Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical r...
KZIA Fundamental Data by TradingView

News

Kazia Therapeutics executes licensing agreement with QIMR Berghofer Medical
Kazia Therapeutics executes licensing agreement with QIMR Berghofer Medical

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER

PR Newswire KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER PR Newswire SYDNEY, Sept. 12, 2024 SYDNEY, Sept. 12, 2024 /PRNewswire/ -- Kazia...\n more…

Kazia Therapeutics (NASDAQ:KZIA) Stock Price Up 8.1%
Kazia Therapeutics (NASDAQ:KZIA) Stock Price Up 8.1%

Ticker Report Shares of Kazia Therapeutics Limited (NASDAQ:KZIA - Get Free Report) rose 8.1% during trading on Monday . The stock traded as high as $0.44 and last traded at $0.42. Approximately 1,220,200 shares...\n more…

Kazia Therapeutics (NASDAQ:KZIA) versus Imunon (NASDAQ:IMNN) Head to Head Review
Kazia Therapeutics (NASDAQ:KZIA) versus Imunon (NASDAQ:IMNN) Head to Head Review

Ticker Report Kazia Therapeutics (NASDAQ:KZIA - Get Free Report) and Imunon (NASDAQ:IMNN - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two...\n more…

Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nKazia Therapeutics stock is a fast mover in both directions and has long-term rally potential after Kazia Therapeutics' clinical...\n more…

Kazia Therapeutics (NASDAQ:KZIA) and Organogenesis (NASDAQ:ORGO) Head to Head Review
Kazia Therapeutics (NASDAQ:KZIA) and Organogenesis (NASDAQ:ORGO) Head to Head Review

Zolmax Organogenesis (NASDAQ:ORGO - Get Free Report) and Kazia Therapeutics (NASDAQ:KZIA - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...\n more…